The association between IL17, fatigue and quality of life in psoriatic arthritis patients

References

• López-Ferrer A, Laiz-Alonso A. Psoriatic arthritis: an update. Actas Dermo-Sifiliográficas. 2014;105(10):913–922.
   PubMedGoogle Scholar
• Husni ME. Comorbidities in psoriatic arthritis. Rheum Dis Clin North Am. 2015;41(4):677–698.
   PubMed Web of Science ®Google Scholar
• Carneiro C, Chaves M, Verardino G, et al. Fatigue in psoriasis with arthritis. Skin Med. 2011;9(1):34–37.
   PubMedGoogle Scholar
• Watt T, Groenvold M, Bjorner JB, et al., Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Community Health. 54(11): 827–833. 2000. .
   PubMed Web of Science ®Google Scholar
• Skoie IM, Ternowitz T, Jonsson G, et al. Fatigue in psoriasis: a phenomenon to be explored. Br J Dermatol. 2015;172(5):1196–1203.
   PubMed Web of Science ®Google Scholar
• Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol. 2001;28(8):1842–1846.
   PubMed Web of Science ®Google Scholar
• Salaffi F, Carotti M, Gasparini S, et al. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcome. 2009;7(1):25.
   PubMedGoogle Scholar
• Martínez-García E, Arias-Santiago S, Valenzuela-Salas I, et al. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. 2014;71(2):302–307.
   PubMed Web of Science ®Google Scholar
• Taylor WJ. Impact of psoriatic arthritis on the patient: through the lens of the WHO international classification of functioning, health, and disability. Curr Rheumatol Rep. 2012;14:369–374.
   PubMed Web of Science ®Google Scholar
• Gaffen SL, Kramer JM, Yu JJ, et al. The IL‚Ae17 cytokine family. In: Gerald L, editor. Vitamins & Hormones. Academic Press; 2006. p. 255–282.
   Google Scholar
• Lubrano E, Perrotta FM. Secukinumab. For ankylosing spondylitis and psoriatic arthritis. Ther Clin Risk Manag. 2016;12:1587–1592. .
   PubMed Web of Science ®Google Scholar
• Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665–2673.
   PubMed Web of Science ®Google Scholar
• Schoels M, Aletaha D, Funovits J, et al. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis. 2010;69:1441–1447.
   PubMed Web of Science ®Google Scholar
• Webster K, Cella D, Yost K. The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.
   PubMedGoogle Scholar
• Brodszky V, Pentek M, Balint PV, et al. Comparison of the psoriatic arthritis quality of life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Scand J Rheumatol. 2010;39(4):303–309.
   PubMed Web of Science ®Google Scholar
• Blackmore MG, Gladman DD, Husted J, et al. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol. 1995 May;22(5):886–893.
   PubMed Web of Science ®Google Scholar
• Levesque R. SPSS programming and data management: a guide for SPSS and SAS users. 4th ed. Chicago: SPSS Inc.; 2007.
   Google Scholar
• Salahadeen E, Torp-Pedersen C, Gislason G, et al. Nationwide population-based study of cause-specific death rates in patients with psoriasis. J Eur Acad Dermatol Venereol. 2015;29(5):1002–1005.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(2):14–17.
   Google Scholar
• The LE. Assessment of disease activity in psoriatic arthritis: MDA, VLDA, DAPSA, or something else? J Rheumatol. 2019;46(7):663–664.
   PubMed Web of Science ®Google Scholar
• Włodarczyk MK, Saczonek AO, Placek W. Prevalence and severity of fatigue in psoriasis and psoriatic arthritis. Adv Dermatol Allergol. 2020;37(1):46–51. .
   PubMed Web of Science ®Google Scholar
• McKenna SP, Doward LC, Whalley D, et al. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis. 2004;63:162–169.
   PubMed Web of Science ®Google Scholar
• Husted JA, Tom BD, Schentag CT, et al. Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis. 2009;68:1553–1558.
   PubMed Web of Science ®Google Scholar
• Kenar G, Yarkan H, Zengin B, et al. Gender does not make a difference in “composite psoriatic disease activity index (CPDAI)” in patients with psoriatic arthritis. Rheumatol Int. 2018;38(11):2069–2076.
   PubMed Web of Science ®Google Scholar
• Nas K, Capkin E, Dagli AZ, et al. Gender specific differences in patients with psoriatic arthritis. Mod Rheumatol. 2017;27(2):345–349.
   PubMed Web of Science ®Google Scholar
• Duruöz MT, Gezer HH, Nas K, et al. The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network. Rheumatol Int. 2020;40(11):1803-1815.
   Google Scholar
• Treharne GJ, Lyons AC, Hale ED, et al. Predictors of fatigue over 1 year among people with rheumatoid arthritis. Psychol Health Med. 2008;13(4):494–504.
   PubMedGoogle Scholar
• Pollard LC, Choy EH, Gonzalez J, et al. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatol (Oxford). 2006;45(7):885–889.
   PubMed Web of Science ®Google Scholar
• Tobin AM, Sadlier M, Collins P, et al., Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study. Br J Dermatol. 176(3): 827–828. 2017. .
   PubMed Web of Science ®Google Scholar
• Queiro R, Pardo E, Charca L, et al. Analysis by age group of disease outcomes in patients with psoriatic arthritis: a cross-sectional multicentre study. Drugs Aging. 2020;37(2):99–104.
   PubMed Web of Science ®Google Scholar
• Tillett W, Shaddick G, Askari A, et al. Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study. Rheumatol (Oxford). 2015;54(1):157–162.
   PubMed Web of Science ®Google Scholar
• Skougaard M, Jørgensen TS, Rifbjerg-Madsen S, et al. Relationship between fatigue and inflammation, disease duration, and chronic pain in psoriatic arthritis: an observational DANBIO registry study. J Rheumatol. 2020;47(4):548–552.
   PubMed Web of Science ®Google Scholar
• Sampogna F, Chren MM, Melchi CF, et al. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006;154(2):325–331.
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK. The psoriasis life stress inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol. 1995;75(3):240–243.
   PubMed Web of Science ®Google Scholar
• Mease PJ, McInnes IB, Kirkham B, et al. Secukinumab inhibition of Interleukin-17A in patients with psoriatic arthritis. N Engl J Med. 2015;373:1329–1339.
   PubMed Web of Science ®Google Scholar
• Naik GS, Ming WK, Magodoro IM, et al. Th17 inhibitors in active psoriatic arthritis: a systematic review and meta-analysis of randomized controlled clinical trials. Dermatology. 2017;233(5):366–377.
   PubMed Web of Science ®Google Scholar
• Baraliakos X, Kivitz AJ, Deodhar AA, et al. Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. Clin Exp Rheumatol. 2018;36(1):50–55.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Mease PJ, Cifaldi MA, et al. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab effectiveness in psoriatic arthritis trial. Ann Rheum Dis. 2007;66(2):163–168.
   PubMed Web of Science ®Google Scholar
• Verhoeven EW, Kraaimaat FW, Van De Kerkhof PC, et al. Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practice. Br J Dermatol. 2007;156:1346–1349.
   PubMed Web of Science ®Google Scholar
• Carneiro C, Chaves M, Verardino G, et al. *Evaluation of fatigue and its correlation with quality-of-life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis. Clin Cosmet Investig Dermatol. 2017;10:155–163.
   PubMed Web of Science ®Google Scholar
• Khallaf MK, AlSergany MA, El-Saadany HM, et al., Assessment of fatigue and functional impairment in patients with rheumatic diseases. J Egypt Rheumatol. 42(1): 51–56. 2020. .
   Web of Science ®Google Scholar